Health

NAFDAC approves emergency use of Johnson & Johnson COVID-19 vaccine

1 Mins read

The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the use of the Johnson & Johnson COVID-19 vaccine in Nigeria.

The vaccine is to be administered to persons from eighteen years of age.

The vaccine is the third vaccine recommended in Nigeria for preventing COVID-19. NAFDAC had already approved the use of the Oxford-AstraZeneca jab.

the director-general of NAFDAC Mojisola Adeyeye said the Ministry of Health and National Primary Health Care Development Agency will announce when the vaccine becomes available for use in Nigeria.

She explained that after a thorough evaluation, the NAFDAC Vaccine Committee concluded that the data on the vaccine were robust and met criteria for efficacy, safety and quality adding that the data also show that the vaccine’s known and potential benefits outweigh its known and potential risks thereby supporting the manufacturer’s recommended use.

Adeyeye noted that Janssen COVID-19 Vaccine is administered as a single dose and results from a clinical trial involving people in the United States, South Africa and Latin American countries found it was effective at preventing COVID-19 in people from 18 years of age.

According to her, the Phase III clinical trial involved over 44,000 people and half received a single dose of the vaccine and half were given placebo (a dummy injection). “People did not know if they had been given Janssen COVID-19 Vaccine or placebo”.

She said, “The trial found a 67% reduction in the number of symptomatic COVID-19 cases after 2 weeks in people who received Janssen COVID-19 Vaccine. The most commonly reported side effects were pain at the injection site, headache, fatigue, muscle aches and nausea. Most of these side effects were mild to moderate in severity and lasted 1-2 days.

On the safety of the vaccine, Adeyeye said that in line with the NAFDAC’s Pharmacovigilance and safety monitoring plan for COVID-19 vaccines, Janssen COVID-19 Vaccine will be closely monitored and subject to several activities that apply specifically to COVID-19 vaccines.

She said, “Manufacturers are required to provide monthly safety reports in addition to the regular updates generated by NAFDAC activities. Janssen COVID-19 Vaccine works by preparing the body to defend itself against COVID-19.! Unopened vaccine vials can be stored and/or transported frozen at -25°C to – 15°C for up to 24 months and 3 months when stored at 2 to 8°C”.

   

About author
Time Nigeria is a general interest Magazine with its headquarters in Abuja, the nation’s Capital.
Articles
Related posts
Abuja FileAll The NewsCover StoryEducationHealthNews

National Orthopaedic Hospital Jos Denies Negligence in Student Nurse’s Death, Cites Crowd Interference

2 Mins read
The management of the National Orthopaedic Hospital, Jos, has dismissed misleading reports surrounding the medical treatment of late Bilat Raphael, a student…
Abuja FileAll The NewsCover StoryHealthLifestyleNewsProfile

Ghana Honours Moji Makanjuola: The African Media Doyenne Turned Journalism into an Instrument for Saving Lives 

12 Mins read
From pioneering health journalism and women’s advancement to public health advocacy, civil society leadership and strategic public relations, Chief Moji Makanjuola’s continental…
Abuja FileCover StoryEducationHealthNews

NMCN Approves Nursing Training for 100 Students at AbdulRasaq Abubakar Toyin University

1 Mins read
…Approval Takes Effect October 2026, Pending NUC Accreditation The Nursing and Midwifery Council of Nigeria (NMCN) has granted approval to the proposed…
Stay on the loop!

Subscribe to our latest news.

Leave a Reply

WP2Social Auto Publish Powered By : XYZScripts.com